We focus on the development, manufacture, and sale of intermediate raw materials for clinical diagnostic reagents and medical device systems. In particular, we provide highly accurate cancer risk tests using our proprietary technology that can supplement and separate sugar chains specific to substances derived from cancer cells. This technology enables a simple test using saliva and is expected to facilitate early cancer diagnosis.

The IT Lab is also active in the field of genomic medicine, aiming to provide a next-generation medical platform. In this way, we aim to provide the best possible treatment for each individual patient.

more